[Edaily Starin Gim Ga Yeong Reporter] Disney+ has officially announced the production of “God’s Speed,” a spin-off of “War of Destiny 49,” which deals with K-shamanism. Photo: Disney+Disney+ announced on the 30th, “We have confirmed the production of ‘Shinpal Stay,’ a spin-off of ‘War of Destiny 49.’” “Shinpal Stay” is a K-shamanism healing tour in which fortune-tellers with strong divine power check in on the destinies of global guests, and it is set to build a powerful K-shamanism universe alongside “War of Destiny 49.” The top three contestants—including “War of Destiny 49” winner Yoon Dae-man, as well as Seol-hwa and Lee So-bin—are reuniting, promising explosive divine power synergy. Anticipation is also high for the addition of shamans who made a strong impression, such as 19-year-old rookie shaman Ji-seon and the handsome shaman Mae-hwa. The destiny sorcerers plan to offer not only a K-shamanism tour exclusively for guests but also everything from meals to counseling for personal concerns. Disney+ stated, “The flood of applications from around the world for the ‘Shaman Stay’ guest recruitment held last May demonstrated the fervor surrounding K-Shamanism, which has gained traction thanks to ‘War of Destiny 49,’” and “As soon as guest recruitment began, we were inundated with stories from applicants in 42 countries worldwide, including the U.S., Japan, France, Mexico, India, and Rwanda.” “War of Destiny 49” is a supernatural survival series in which 49 fortune-tellers gather to test their destinies through various missions. It was released last February and has gained popularity both domestically and internationally. Meanwhile, “Divine Stay” is set to premiere on Disney+ in 2027.
KBI METAL CO., LTD.’s Eumseong Plant Office Building. (Photo courtesy of KBI Group)
KBI METAL CO., LTD. posted its highest-ever cumulative operating profit for the first three quarters of this year,…
Lotte Group will hold board meetings for its affiliates as early as the 16th to carry out its regular executive reshuffle. Following last year’s replacement of 20 chief executive officers (CEOs), all …
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…